April 2014
Volume 55, Issue 13
ARVO Annual Meeting Abstract  |   April 2014
Risk of Leaving the Workforce in Non-infectious Uveitis
Author Affiliations & Notes
  • Namita Tundia
    AbbVie Inc., North Chicago, IL
  • Martha Skup
    AbbVie Inc., North Chicago, IL
  • Rachael Sorg
    Analysis Group, Inc., New York, NY
  • Dendy Macaulay
    Analysis Group, Inc., New York, NY
  • Jingdong Chao
    AbbVie Inc., North Chicago, IL
  • Parvez Mulani
    AbbVie Inc., North Chicago, IL
  • Jennifer E Thorne
    Johns Hopkins School of Medicine, Baltimore, MD
  • Footnotes
    Commercial Relationships Namita Tundia, AbbVie (E), AbbVie (I); Martha Skup, AbbVie (E), AbbVie (I); Rachael Sorg, AbbVie (F), Analysis Group (E); Dendy Macaulay, AbbVie (F), Analysis Group (E); Jingdong Chao, AbbVie (E), AbbVie (I); Parvez Mulani, AbbVie (E), AbbVie (I); Jennifer Thorne, AbbVie (C), Allergan (F), Gilead (C), NEI (F), NIAID (F), RPB (F), The Wilmer Eye Institute, Johns Hopkins School of Medicine (E), XOMA (C)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 5309. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Namita Tundia, Martha Skup, Rachael Sorg, Dendy Macaulay, Jingdong Chao, Parvez Mulani, Jennifer E Thorne; Risk of Leaving the Workforce in Non-infectious Uveitis. Invest. Ophthalmol. Vis. Sci. 2014;55(13):5309.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Non-infectious uveitis (NIU) is a spectrum of diseases characterized by intraocular inflammation of uvea that may cause disabling visual impairment. We assessed risk of leaving the workforce among privately insured US employees with non-anterior NIU compared with matched controls.


Patients aged 18-64 with ≥2 occurrences of diagnoses of non-anterior NIU (ICD-9: 360.12, 362.12, 362.18, 363.0x, 363.10-363.13, 363.15, 363.2x, 364.24) from 1/1/1998 to 3/31/2012 were identified in the OptumHealth claims database. Patients had continuous eligibility for ≥6 months before their first non-anterior NIU diagnosis (index date). Patients with non-anterior NIU (cases) were matched 1:1 by age, sex, region, employment status, and company to controls without a diagnosis of uveitis (infectious or non-infectious). Patients were actively employed on the index date and were followed until loss of insurance eligibility or until age 65. Risks of leaving the workforce (leave of absence, early retirement, short-term disability, or long-term disability) were compared between cases and controls using time-to-event Kaplan-Meier analysis and Cox proportional hazard regressions adjusting for baseline characteristics.


Cases and controls (N=776 each) were 61.9% male; mean age was 44.7 years. In unadjusted Kaplan-Meier analyses, risk of leaving the workforce was significantly higher in cases vs. controls (P=.0069); risk among cases at 5- and 10-years was 31.3% and 43.9% while that among controls was 23.4% and 33.1%, respectively (figure). Risks of leave of absence at 5- and 10-years were 14.9% and 19.8% for cases vs. 10.5% and 12.9% for controls; risk of long-term disability at 5- and 10-year were 3.7% and 6.0% for cases vs. 1.2% and 2.8% for controls (all comparisons P<.05). Risk of early retirement and short-term disability were also greater for NIU vs. controls; however, differences in time to early retirement and time to short-term disability were not statistically significant. Results were supported by regression analysis; cases were significantly more likely to leave the workforce over the course of follow-up vs. controls (adjusted hazard ratio=1.27, 95% CI=1.01-1.59, P=.039).


Compared with matched controls, patients with NIU were more likely to leave the workforce. Substantial burden due to loss of workforce participation is associated with NIU.

Risk of Leaving the Workforce
Risk of Leaving the Workforce
Keywords: 746 uveitis-clinical/animal model • 557 inflammation • 745 uvea  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.